Status:
COMPLETED
Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role?
Lead Sponsor:
The Cleveland Clinic
Conditions:
Quality of Recovery
Same Day Surgery
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
To the investigators knowledge there are no studies in the literature evaluating the effect of Dexamethasone administration on patients undergoing outpatient vaginal prolapse surgeries.
Detailed Description
The lifetime risk of undergoing surgical intervention for pelvic organ prolapse (POP) is estimated to be 10% and it is projected that from 2010 to 2050, the number of surgeries for POP will rise by 47...
Eligibility Criteria
Inclusion
- Women over the age of 18
- Women scheduled for vaginal POP reconstructive surgery with or without concomitant anti-incontinence procedure and with or without hysterectomy
- ASA class 1-2
Exclusion
- Daily use of steroids, antiemetics in the month prior to surgery
- Chronic pain requiring daily opioid treatment
- History of allergy/intolerance to Dexamethasone
- ASA class 3
- Numerical Pain score of more than 4 at baseline
- Renal/Liver disease
- Diabetes mellitus
- Pregnancy
- Inability to answer questionnaires
- Any systemic infections
- Immuno compromised status
- Patients with planned overnight stay
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 21 2018
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT03338400
Start Date
May 1 2017
End Date
August 21 2018
Last Update
April 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Florida
Weston, Florida, United States, 33331